Donald P McDonnell Selected Research

Donald P McDonnell Research Topics

Disease

55	Neoplasms (Cancer) 06/2022 - 01/2005
48	Breast Neoplasms (Breast Cancer) 12/2021 - 03/2002
21	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 04/2002
11	Neoplasm Metastasis (Metastasis) 01/2021 - 09/2009
5	Osteoporosis 01/2019 - 07/2002
3	Hypercholesterolemia 10/2017 - 03/2013
3	Triple Negative Breast Neoplasms 01/2017 - 04/2016
3	Inflammation (Inflammations) 01/2015 - 08/2007
2	Melanoma (Melanoma, Malignant) 12/2021 - 12/2014
2	Obesity 10/2017 - 09/2014
2	Disease Progression 01/2017 - 01/2013
2	Heart Failure 09/2014 - 01/2011
2	Macular Degeneration (Age-Related Maculopathy) 10/2013 - 02/2011
2	Metabolic Diseases (Metabolic Disease) 08/2010 - 12/2007
2	Cardiovascular Diseases (Cardiovascular Disease) 04/2009 - 10/2008
1	Autoimmune Diseases (Autoimmune Disease) 06/2022
1	Disease Resistance 12/2021
1	Carcinoma (Carcinomatosis) 01/2017

Drug/Important Bio-Agent (IBA)

20	Estrogens (Estrogen)FDA Link 06/2022 - 01/2005
20	Estrogen ReceptorsIBA 12/2021 - 11/2008
19	Androgen Receptors (Androgen Receptor)IBA 01/2018 - 11/2003
17	AndrogensIBA 01/2018 - 04/2002
12	Selective Estrogen Receptor Modulators (SERM)IBA 01/2020 - 07/2002
11	Proteins (Proteins, Gene)FDA Link 10/2019 - 03/2009
10	LigandsIBA 10/2019 - 04/2002
9	CholesterolIBA 01/2021 - 01/2008
9	Tamoxifen FDA LinkGeneric 11/2015 - 05/2005
8	Fulvestrant (Faslodex)FDA Link 12/2021 - 10/2007
8	Hormones (Hormone)IBA 01/2019 - 05/2004
8	27-hydroxycholesterolIBA 10/2017 - 08/2010
8	EnzymesIBA 10/2017 - 09/2008
7	Estrogen Receptor alphaIBA 10/2019 - 03/2002
7	ERRalpha Estrogen-Related ReceptorIBA 01/2019 - 12/2006
7	Aromatase InhibitorsIBA 01/2019 - 12/2005
7	Pharmaceutical PreparationsIBA 01/2019 - 12/2010
5	Androgen Antagonists (Antiandrogens)IBA 10/2016 - 04/2002
4	Transcription Factors (Transcription Factor)IBA 12/2021 - 05/2010
4	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 03/2009
3	enzalutamideIBA 01/2018 - 10/2016
3	OxysterolsIBA 10/2017 - 03/2013
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2017 - 04/2010
3	LipidsIBA 01/2017 - 02/2011
3	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2015 - 02/2010
3	Small Interfering RNA (siRNA)IBA 07/2012 - 11/2008
3	Messenger RNA (mRNA)IBA 04/2010 - 03/2009
2	Immune Checkpoint InhibitorsIBA 06/2022 - 12/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2019
2	A-Form DNA (A-DNA)IBA 01/2021 - 05/2010
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2020 - 11/2015
2	Calcium-Calmodulin-Dependent Protein Kinase KinaseIBA 01/2019 - 01/2011
2	Pyruvic Acid (Pyruvate)IBA 01/2019 - 12/2006
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 04/2016
2	Androgen Receptor AntagonistsIBA 01/2018 - 07/2009
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2017 - 01/2017
2	Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA 06/2017 - 01/2017
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 06/2017 - 11/2013
2	bicalutamide (Casodex)FDA LinkGeneric 10/2016 - 07/2009
2	hydroxyflutamideIBA 10/2016 - 07/2009
2	Indicators and Reagents (Reagents)IBA 04/2016 - 04/2009
2	CopperIBA 06/2015 - 10/2014
2	Disulfiram (Antabuse)FDA Link 06/2015 - 10/2014
2	Liver X ReceptorsIBA 11/2013 - 02/2011
2	Aromatase (CYP19)IBA 05/2013 - 07/2011
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 02/2011 - 04/2005
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 02/2011 - 08/2007
2	Orphan Nuclear ReceptorsIBA 11/2010 - 11/2008
2	Estrogen Receptor Modulators (Antiestrogen)IBA 10/2007 - 01/2005
2	3- (4- (1,2- diphenylbut- 1- enyl)phenyl)acrylic acidIBA 10/2007 - 05/2005
1	LasofoxifeneIBA 01/2020
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2020
1	Blocking AntibodiesIBA 10/2019
1	Humanized Monoclonal AntibodiesIBA 10/2019
1	NADP (NADPH)IBA 01/2019
1	Oxygen (Dioxygen)IBA 01/2019
1	ChemokinesIBA 01/2019
1	mahuang-tangIBA 01/2019
1	Sex Hormone-Binding GlobulinIBA 01/2019
1	25-hydroxyvitamin DIBA 01/2019
1	LSZ102IBA 12/2018
1	histone deacetylase 3IBA 01/2018
1	Vorinostat FDA Link 01/2018
1	Histone Deacetylase InhibitorsIBA 01/2018
1	Proteolysis Targeting ChimeraIBA 01/2018
1	snake venom protein C activatorIBA 01/2018
1	RGFP966IBA 01/2018
1	abirateroneIBA 06/2017
1	seviteronelIBA 06/2017
1	human ERBB2 proteinIBA 01/2017
1	Trastuzumab (Herceptin)FDA Link 01/2017
1	Lapatinib (GW572016)FDA Link 01/2017
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2017
1	Sterol Regulatory Element Binding Protein 2IBA 01/2017
1	LDL Receptors (LDL Receptor)IBA 01/2017
1	Atorvastatin (Lipitor)FDA Link 01/2017
1	Docetaxel (Taxotere)FDA Link 01/2017

Therapy/Procedure

31	Therapeutics 12/2021 - 05/2004
6	Drug Therapy (Chemotherapy) 01/2021 - 09/2008
4	Castration 01/2018 - 10/2016
1	Immunotherapy 01/2019
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2019